A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...

The median time-to-next-treatment (defined as the time from the date of the first dose of tovorafenib to the start of the first subsequent anticancer treatment, or date of death) was 42.6 months (95% ...

Day One Biopharmaceuticals (DAWN) announced three-year results from the OJEMDA pivotal Phase 2 FIREFLY-1 trial in an oral presentation at the 30th ...

J&J (JNJ) stock and Halozyme Therapeutics (HALO) stock are in focus as their multiple myeloma therapy Darzalex Faspro is granted traditional FDA nod. Read more here.

If you've taken the plunge to move more, eat better, or have returned to your routine after a break, congratulations! You're ...